09/08/2026
At 67, Stephanie Tebow was dealing with a painful rotator cuff injury that had progressed from two small tears into a larger tear along with arthritis, bursitis, and bone edema in the shoulder.
After researching her options, she decided to explore stem cell and PRP treatment with R3 Stem Cell Beverly Hills.
What happened next wasn’t an overnight transformation.
Stephanie describes experiencing significant pain during the first few months and says her progress took time. She continued to monitor her shoulder and waited for her follow-up imaging.
A year after treatment, her imaging showed changes that, in her words, made the experience “worth every penny.”
Her biggest takeaway?
Have realistic expectations, give your body time, and follow your progress.
Watch Stephanie share her experience, from the challenges of recovery to what she saw on her follow-up imaging.
Interested in learning whether regenerative medicine may be an option for your situation?
Schedule a free consultation with R3 Stem Cell.
☎+1 424-382-1074
📍9301 Wilshire Blvd, Beverly Hills, CA, United States, 90210
Disclaimer:
Stem cell therapy is considered experimental and is regulated by the U.S. Food and Drug Administration (FDA), but it is not FDA-approved. R3 Stem Cell does not offer stem cell therapy as a cure for any medical condition. No statements made on this page have been evaluated or approved by the FDA. This page does not provide medical advice. All content is for informational purposes only and is not a substitute for professional medical consultation, diagnosis, or treatment. Reliance on any information provided by R3 Stem Cell, its employees, others appearing on this page at the invitation of R3 Stem Cell, or other visitors to the page is solely at your own risk. R3 Stem Cell does not recommend or endorse any specific tests, products, procedures, opinions, or other information that may be mentioned on this website. R3 Stem Cell is not responsible for the outcome of your procedure. The FDA considers stem cell therapy experimental at this point.